Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29715056

Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Jul 1
First author
Stilgenbauer S

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 Jul 1;36(19):1991-1993. doi: 10.1200/JCO.2018.78.2763.
    note
    Source null
    related pmid
    29787358
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Sep 1;37(25):2299. doi: 10.1200/JCO.19.00384.
    note
    Source null
    related pmid
    31461633
    relationship
    Erratum in

Authors and identifiers

  1. name
    Stilgenbauer S
    type
    Author
  2. name
    Eichhorst B
    type
    Author
  3. name
    Schetelig J
    type
    Author
  4. name
    Hillmen P
    type
    Author
  5. name
    Seymour JF
    type
    Author
  6. name
    Coutre S
    type
    Author
  7. name
    Jurczak W
    type
    Author
  8. name
    Mulligan SP
    type
    Author
  9. name
    Schuh A
    type
    Author
  10. name
    Assouline S
    type
    Author
  11. name
    Wendtner CM
    type
    Author
  12. name
    Roberts AW
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Stilgenbauer S
    type
    Author
  2. name
    Eichhorst B
    type
    Author
  3. name
    Schetelig J
    type
    Author
  4. name
    Hillmen P
    type
    Author
  5. name
    Seymour JF
    type
    Author
  6. name
    Coutre S
    type
    Author
  7. name
    Jurczak W
    type
    Author
  8. name
    Mulligan SP
    type
    Author
  9. name
    Schuh A
    type
    Author
  10. name
    Assouline S
    type
    Author
  11. name
    Wendtner CM
    type
    Author
  12. name
    Roberts AW
    type
    Author
bibliography ids
  1. nci-bib-79aca3ff01a4bc7601656b3f
book metadata
content sha256
8b790347156c197ca899c25bb4654abc5e434e1f924de6bdc3de336ca3534d02
document type
citation
dois
  1. 10.1200/JCO.2017.76.6840
electronic publication date
display
2018 May 1
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29715056
immutable id
pubmed:29715056@8b790347156c197ca899c25bb4654abc5e434e1f924de6bdc3de336ca3534d02
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
19
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1973-1980
volume
36
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 Jul 1;36(19):1991-1993. doi: 10.1200/JCO.2018.78.2763.
    note
    Source null
    related pmid
    29787358
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2019 Sep 1;37(25):2299. doi: 10.1200/JCO.19.00384.
    note
    Source null
    related pmid
    31461633
    relationship
    Erratum in
outcomes validated
false
pmid
29715056
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
369c43c0b57d13fa02c02dd8578a18cc4d6cd9d34886cb77e8bc026bc4e6772e
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Jul 1
precision
day
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29715056/
title
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial.

Preserved source evidence · Not medical advice